TVP23BP2

Across TCGA pan-cancer cohorts, TVP23BP2 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TVP23BP2 data layer compared with 12 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher TVP23BP2 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated TVP23BP2 expression acts as an unfavorable survival marker.

HNSC, PDAC, and LSCC are the cancer types where TVP23BP2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Quartile	All	0.562	0.929	.011	10	view →
PDAC	DFS	Quartile	II,III,IV	0.297	0.789	.038	3	view →
LSCC	DFS	Median	All	0.900	1.000	.044	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TVP23BP2–HNSC (DFS)

Open the HNSC breakdown →